InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.16%
)
US TECH 100
19,177.20
(
-0.20%
)
Dow Jones
39,127.80
(
0.04%
)
Brent Oil
84.99
(
0.62%
)
Bitcoin
60,849.35
(
0.06%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DonShimoda

Send PM Follow Ignore
Followers 19
Posts 727
Boards Moderated 0
Alias Born 11/10/2009

DonShimoda

Re: BTH post# 3876

Monday, 12/06/2010 1:16:22 PM

Monday, December 06, 2010 1:16:22 PM

Post# of 80490

which is what I said earlier.


Maybe you have a different definition of head to head. In my world its one drug vs another, mano a mano, you know like imatinib vs dasatinib.

Whether you care to admit it or not, Dr. Kantarjian specifically suggested that Ariad NOT run a large, head to head trial....which IS exactly what you were suggesting.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up